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Dong-Yan Jin1*, Yun-Bo Shi2 and T-C Wu3Talking about the golden era of the National Institutes
of Health (NIH), Nobel laureates Joseph Goldstein and
Michael Brown concluded in a recent issue of Science
that "ambitious young physicians juxtaposed to cutting-
edge basic scientists can themselves make fundamental
discoveries" [1]. In our minds, both the late George
Khoury and his postdoc Kuan-Teh Jeang, known as
“Teh” among friends and colleagues, were in that group
of brilliant NIHers who broke new ground in many areas
of biomedical research, particularly in the study of
retroviruses. When one of us, Dong-Yan Jin, joined Teh's
laboratory at NIH in 1994, he learned from Teh not only
about George Khoury’s scientific achievements but also
about his strong commitments to friends, family and
community. Although he died much too early at the age
of 43 in 1987, George was Teh's role model and
influenced him greatly in his professional life. They
shared many things in common, most importantly their
devotion to science and people. As a recognition of his
scientific achievements, Teh was chosen to deliver the
2012 George Khoury Lecture at NIH in October 2012
on "Nuclear damage and aneuploidy: human T cell
leukemia virus transformation of cells". Teh was such an
energetic and tireless person that NIH deputy Director
Michael Gottesman described him as a dynamo at that
lecture. Teh's sudden and unexpected passing in the late
evening of January 27, 2012 saddened all of us
completely.
Teh had been working at the NIH for 27 years and
was chief of the Molecular Virology Section in the La-
boratory of Molecular Microbiology of the National In-
stitute of Allergy and Infectious Diseases. He led a
highly productive group and published more than 250
scientific papers in the broad field of biomedical science,
with a focus on two human retroviruses: human im-
munodeficiency virus type 1 (HIV-1) and human T-cell* Correspondence: dyjin@hku.hk
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reproduction in any medium, provided the orleukemia virus type 1 (HTLV-1). Many of his scientific
discoveries were seminal and paradigm-shifting. His
findings revealed new clues to fundamental questions
such as how HIV-1 transcribes its RNA and how HTLV-
1 transforms cells. They had important implications in
disease prevention and intervention. Teh trained more
than 30 postdocs, many of whom moved on to faculty
positions in the US, Europe and Asia. Their association
with Teh was critical to the advancement of their scien-
tific career.
Teh was a scientific leader in HIV research. In 1989
Teh discovered that the activation of HIV-1 long ter-
minal repeats by viral transactivator Tat requires a highly
structured RNA hairpin termed TAR [2]. This was a
conceptual breakthrough that forever changed the field
of transcriptional regulation. In addition, it also provided
the foundation for rational design and development of
RNA therapeutics for the treatment of AIDS. These
therapeutic RNA decoys and aptamers block HIV-1
transcription by perturbing the function of TAR. Some
of them have been tested in clinical trials. As a continu-
ation of his work on TAR, Teh identified a cellular TAR-
binding protein named TRBP in 1991 by screening a
cDNA expression library with a TAR RNA probe [3].
TRBP was later found to be a binding partner and regu-
lator of double stranded RNA-dependent protein kinase
PKR and Dicer protein that mediates RNA interference.
Interestingly, a small molecule activator of TRBP was re-
cently identified by others through a chemical screen.
This compound named enoxacin can enhance TRBP-
mediated microRNA processing and therefore exhibits
cancer-specific and TRBP-dependent growth inhibitory
effects [4]. Although through a circuitous route, Teh's
identification of TRBP led to the development of a new
agent that holds promise for the treatment of cancer.
Research on HTLV-1 that causes adult T-cell leukemia
was another area close to Teh’s heart. He started his
work on HTLV-1 when he was with George Khoury.
Over the years he laid a number of cornerstones that
shaped the field. His studies not only provided molecularThis is an Open Access article distributed under the terms of the Creative
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by HTLV-1 oncoprotein Tax mediated through CREB and
NF-κB, but also derived mechanistic insights into Tax-
induced oncogenic transformation of T lymphocytes.
Existing and emerging evidence now supports his ideas
that Tax creates genome instability by perturbing DNA
damage response, mitotic checkpoint and centrosomal du-
plication [5]. Because frontline chemotherapeutic drugs
for cancer target the DNA damage response or mitotic
checkpoint, Teh’s findings had important therapeutic
implications. In his George Khoury lecture delivered in
October 2012, he summarized a part of his work on
HTLV-1, which focuses on genome integrity and aneu-
ploidy. Undoubtedly, Teh’s thoughts and findings will con-
tinue to have substantial and long-lasting impacts on
HTLV-1 research.
While he made every effort to get to the bottom of the
research questions he was asking, Teh always kept his
curiosity alive and was ready to embrace serendipity. In
his study of HIV-1 TAR he coincidentally identified
TRBP [3], which is now known to be a key player in
RNA interference. In his study of HTLV-1 Tax he identi-
fied MAD1 which is a core component of mitotic check-
point [6]. In his study of MAD1 he inadvertently found
that the absence of inner nuclear membrane protein
SUN1 ameliorates laminopathy and premature aging [7].
All these serendipitous discoveries by Teh turned out to
be path-breaking. They opened up avenues for new stud-
ies in several different fields.
In our personal views, in addition to his courage and wis-
dom, Teh’s success in science can also be attributed to
three additional traits. First, he aimed high and worked ex-
tremely hard. One of our colleagues in Hong Kong
received his email sent in the evening of Sunday, January
27, 2013, just hours before his death. In this email he made
suggestions for manuscript preparation. He had been
working essentially 7 days a week for 27 years, even when
the NIH was shut down as a result of the budget battle or
during snowstorms. No matter when and where we sent
him an email, we got a reply immediately or within a few
hours. Such work ethics that he inherited from the older
generation of Chinese Americans was an important factor
in his tremendous success. Second, he managed to make
the best use of cutting-edge technologies to address im-
portant scientific questions. At least one new method was
employed in each of his primary research papers cited
above. For example, yeast two-hybrid technology was used
in the identification of MAD1 [6], whereas double knock-
out mice were made to reveal the novel role of SUN1 in
progeria [7]. He was always enthusiastic about new meth-
odologies and technology development. He was actually
one of the first in the fields of HIV-1 and HTLV-1 to do
RNAi screening, deep sequencing and microRNA profiling.
Finally, he constantly sought to make connections withtalented and competent individuals. He was a serious and
exemplary collaborator. Most of his papers cited above
represent fruitful collaborations with others.
Teh had been very outspoken on issues affecting Asian
American scientists, such as their representation in lead-
ership positions. He joined the Society of Chinese
Bioscientists in America (SCBA) as one of its earliest
lifetime members. He was elected the President of SCBA
for a two-year term from 2011–2012 [8]. During his ten-
ure, Teh organized one of the most successful biennial
meetings both scientifically and financially. He recruited
a large number of new members both in North America
and Asia. His tireless effort in promoting SCBA led to
enormous donations to the society that helped to pro-
vide a solid financial foundation for future development.
In addition, with the long-term view of a strong and suc-
cessful society in mind, Teh envisioned the necessity and
benefit of a society journal. This led him to create the
official SCBA journal, Cell and Bioscience, in 2011 [9].
Teh was also instrumental in the tremendous success of
this new journal, including its acceptance by Thomson
Reuters for tracking, from the very first paper published,
for an Impact Factor to be released later this year [10].
Teh was a superb mentor. He was attentive, supportive
and at times demanding to his postdocs who came from
all over the world. He generously gave personal and
practical help to people in the lab on various issues. Im-
portantly, for everything he asked from his postdocs, he
set himself as a role model for them. Many postdocs be-
came his lifelong friends. His commitments to his
postdocs and friends were always strong. Teh told us
stories about how his mentor George Khoury was caring
and committed to his fellows. In this regard, they both
were the type of supervisors and academic leaders who
were not only outstanding scientists but also great
human beings. Teh’s life was much too short, but his
legacy and our memories of him will last forever. Our
hearts and condolences are with his wife Diane and his
three children David, Diana and John.
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